The HER Foundation continues the breakthroughs with publication of “Whole-exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum” in BJOG.
Read More2021 has been a busy year for HER research, and we’re finding answers to your questions about Hyperemesis Gravidarum (HG). We’ve had papers published and given presentations. We also have papers under review in scientific journals, abstracts being reviewed for presentation at ACOG, new studies being kicked-off, and we are continuing ongoing research projects.
Read MoreHER Board members, Marlena Fejzo, PhD, and Patrick Mullen, MD, are running the first study of GDF15 in HG patients in the United States.
Read MoreMarlena Fejzo, PhD, HER Board Member and Research Advisor, presents at the American Society of Human Genetics Annual Meeting on the genetics of Hyperemesis Gravidarum (HG).
Read MoreRead the latest research on the safety of ondansetron (Zofran) in an HG pregnancy.
Read MoreDr. Marlena Fejzo, a geneticist at the University of Southern California and a HER Foundation Board of Directors, presented at the Fetal Medicine Foundation (FMF) about Hyperemesis Gravidarum (HG), its potential causes, and treatment options. Over 5600 medical professionals heard her speak, and the talk is freely available on the FMF’s website in English, Spanish, Russian, and Portuguese.
Read MoreThe HER Foundation publishes a new study demonstrating the effectiveness of the HyperEmesis Level Prediction (HELP) Score in identifying pregnant women with severe symptoms of NVP.
Read MoreWe had an amazing week at the Society for Maternal-Fetal Medicine (SMFM) 40th Annual Pregnancy Meeting in Grapevine, TX! We were the only organization representing HG, and we personally educated…
Read MoreWhat is the HG breakthrough we co-published in Nature Communications? This study provides scientific evidence linking 2 genes, GDF15 and IGFBP7, to HG. These genes provide the instructions to build…
Read More- « Previous
- 1
- 2
- 3
- Next »